Sanz GF - Search Results

1

Comparison of transfusion requirements in adult patients undergoing Haploidentical or single-unit umbilical cord blood stem cell transplantation.

Solves P, Sanz J, Gómez I, de la Puerta R, Arnao M, Montoro J, Piñana JL, Carretero C, Balaguer A, Guerreiro M, Andreu R, Rodríguez R, Montesinos P, Jarque I, Lorenzo JI, Carpio N, Sanz MÁ, Sanz GF. Solves P, et al. Among authors: sanz ma, sanz j, sanz gf. Eur J Haematol. 2019 Sep;103(3):172-177. doi: 10.1111/ejh.13270. Epub 2019 Jul 3. Eur J Haematol. 2019. PMID: 31177565

2

Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia.

Sempere A, Sanz GF, Senent L, de la Rubia J, Jarque I, López F, Arilla MJ, Guinot M, Martín G, Martínez J, et al. Sempere A, et al. Among authors: sanz gf. Bone Marrow Transplant. 1992 Dec;10(6):495-8. Bone Marrow Transplant. 1992. PMID: 1362686

3

Carboplatin alone or in combination in high-risk acute nonlymphoblastic leukemia.

Sanz MA, Sanz GF, Martínez JA, Senent L, López F, Palau J, Martín G, Jarque I. Sanz MA, et al. Among authors: sanz gf. Ann Oncol. 1992 Aug;3 Suppl 3:39-42. doi: 10.1093/annonc/3.suppl_3.s39. Ann Oncol. 1992. PMID: 1390315 Review.

4

Bone marrow transplantation activity in Europe 1990.

Sanz MA, Sanz GF. Sanz MA, et al. Among authors: sanz gf. Bone Marrow Transplant. 1992 Mar;9(3):217-8. Bone Marrow Transplant. 1992. PMID: 1511260 No abstract available.

5

[Hyperleukocytic acute leukemia. Clinico-biological characterization, response to treatment and prognostic factors].

Senent L, Sanz GF, Jarque I, De la Rubia J, Sanz MA. Senent L, et al. Among authors: sanz ma, sanz gf. Sangre (Barc). 1992 Feb;37(1):25-30. Sangre (Barc). 1992. PMID: 1585234 Spanish.

6

Prognostic value of CD34 expression in de novo acute myeloblastic leukaemia.

Guinot M, Sanz GF, Sempere A, Arilla MJ, Jarque I, Gomis F, Sanz MA. Guinot M, et al. Among authors: sanz ma, sanz gf. Br J Haematol. 1991 Nov;79(3):533-4. doi: 10.1111/j.1365-2141.1991.tb08075.x. Br J Haematol. 1991. PMID: 1721528 No abstract available.

7

Prognostic factors in myelodysplastic syndromes.

Sanz GF, Sanz MA. Sanz GF, et al. Among authors: sanz ma. Leuk Res. 1992;16(1):77-86. doi: 10.1016/0145-2126(92)90105-g. Leuk Res. 1992. PMID: 1732678 Review.

8

[Culture of cells forming granulomonocytic colonies in bone marrow (GM-CFU) in myelodysplastic syndromes and their relation to hematological findings and FAB subtype].

García M, Sanz GF, Arriaga F, Pérez-Sirvent ML, Marty ML, Sanz MA. García M, et al. Among authors: sanz ma, sanz gf. Sangre (Barc). 1991 Aug;36(4):269-75. Sangre (Barc). 1991. PMID: 1776105 Spanish.

9

[Chronic lymphatic leukemia. I. Clinico-biological features and survival analysis. Study of 187 patients].

Jarque I, Sanz G, Gomis F, Martínez G, de la Rubia J, López F, Sanz MA. Jarque I, et al. Sangre (Barc). 1991 Aug;36(4):277-84. Sangre (Barc). 1991. PMID: 1776106 Spanish.

10

[Chronic lymphatic leukemia. II. Analysis of prognostic factors and development of survival predicting models. Study of 187 patients].

Jarque I, Sanz G, Gomis F, Martínez J, Martín G, de la Rubia J, López F, Sanz MA. Jarque I, et al. Sangre (Barc). 1991 Aug;36(4):285-94. Sangre (Barc). 1991. PMID: 1776107 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

370 results

Search Page